BioSig Technologies, Inc.
  • Home
  • About BioSig
    • About BioSig
    • Overview
    • Partnerships
  • Our Technology
    • Our Technology
    • The PURE EP Platform
      • Overview
      • ATC
      • NFT
    • Publications
  • Join Our Team
  • News & Media
    • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Events
  • Investors
    • Investors
    • Overview
    • News / Events
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Information
      • Profile
      • Leadership Team
      • Contacts
      • FAQ
    • Financial Information
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Corporate Governance
      • Board of Directors
      • Governance Documents
  • Contact
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Profile
    • Leadership Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed

Press Releases

  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

BioSig Opens a Technology Development Office in Rochester, MN

October 15, 2019

BioSig to Participate at The 14th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy

October 10, 2019

BioSig to Present Clinical Observations at Venice Arrhythmias 2019

September 30, 2019

Global Marketing and Strategy Leader Martha Pease Joins BioSig Board of Directors

September 26, 2019

BioSig Technologies Signs a New Licensing Agreement with Mayo Clinic

September 12, 2019

BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million

September 5, 2019

BioSig Allowed Additional Foundational US Patent for its PURE EP(tm) System

August 1, 2019

Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs

July 24, 2019

Olivier Chaudoir Joins BioSig as Director of Marketing

July 18, 2019

Manasi Patwardhan Joins BioSig as Director of Strategic Planning

July 11, 2019
rss_feed News RSS
  • Previous
    • 1...
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    • ...37
    Next
    Award
    BioSig Technologies, Inc.
    Sign Up for BioSig Updates Contact Us
    x formerly known as twitter icon X formerly known as Twitter
    linkedin Facebook
    © 2025 BioSig Technologies, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap